COST-MINIMIZATION ANALYSIS TO TWO SURGICAL TREATMENTS OF BENIGN PROSTATIC HYPERPLASIA IN THE BRAZILIAN PRIVATE HEALTH SECTOR

被引：0
|
作者：
Rodrigues, S. [1 ]
Tortele, H. [2 ]
Conto, M. [1 ]
机构：
[1] Boston Sci, Sao Paulo, Brazil
[2] Boston Sci, Santo Andre, SP, Brazil
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
MT5
引用
收藏
页码：S297 / S298
页数：2
相关论文
共 50 条
  • [1] COST-MINIMIZATION ANALYSIS OF DAPTOMYCIN FOR MRSA SKIN AND SOFT TISSUES INFECTIONS IN BRAZILIAN PRIVATE SECTOR
    Bueno, R. L. P.
    Prismich, G.
    Suzuki, C.
    VALUE IN HEALTH, 2008, 11 (06) : A439 - A439
  • [2] Evaluating the Impact of Benign Prostatic Hyperplasia Surgical Treatments on Sexual Health
    Kaltsas, Aris
    Kratiras, Zisis
    Zachariou, Athanasios
    Dimitriadis, Fotios
    Sofikitis, Nikolaos
    Chrisofos, Michael
    BIOMEDICINES, 2024, 12 (01)
  • [3] Economic costs of benign prostatic hyperplasia in the private sector
    Saigal, CS
    Joyce, G
    JOURNAL OF UROLOGY, 2005, 173 (04): : 1309 - 1313
  • [4] Cost-effectiveness analysis of benign prostatic hyperplasia (BPH)treatments
    DiSantostefano, RL
    Biddle, AK
    Lavelle, JP
    JOURNAL OF UROLOGY, 2005, 173 (04): : 8 - 8
  • [5] Cost-effectiveness analysis of benign prostatic hyperplasia (BPH) treatments
    DiSantostefano, R
    Biddle, A
    Lavelle, J
    VALUE IN HEALTH, 2005, 8 (03) : 301 - 302
  • [6] Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia
    Tzortzis, Vassilios
    Gravas, Stavros
    de la Rosette, Jean J. M. C. H.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (06) : 513 - 522
  • [7] COST-MINIMIZATION ANALYSIS OF BIOLOGICAL DRUGS IN THE TREATMENT OF RHEUMATOID ARTHRITIS UNDER THE BRAZILIAN PRIVATE HEALTH SYSTEM PERSPECTIVE
    Scaccabarozzi, L.
    Asano, E.
    Monteiro, A. C.
    VALUE IN HEALTH, 2016, 19 (03) : A234 - A234
  • [8] COST-MINIMIZATION ANALYSIS OF VISCOSUPPLEMENTATION TREATMENT OSTEOARTHRITIS OF KNEE IN BRAZIL'S PRIVATE SECTOR
    Bueno, R. L. P.
    Stefani, S.
    VALUE IN HEALTH, 2009, 12 (07) : A523 - A524
  • [9] Cost-effectiveness analysis of medical treatment of benign prostatic hyperplasia in the Brazilian public health system
    Bahia, Luciana Ribeiro
    Araujo, Denizar Vianna
    Pepe, Camila
    Trindade, Michelle
    Camargo, Caroline Mendonca
    Javaroni, Valter
    INTERNATIONAL BRAZ J UROL, 2012, 38 (05): : 595 - 605
  • [10] Cost analysis of alpha blocker treatments for benign prostatic hyperplasia in Medicare beneficiaries
    Sidi, Yulia
    Duan, Yinghui
    Rhee, Taeho Greg
    Wu, Z. Helen
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2021, 17 (06): : 1119 - 1139
12345